Transaction · 0000950170-25-032248

LEONARD JOHN M

LEONARD JOHN M, PRES, reported a transaction classified as grant at Intellia Therapeutics, Inc. involving 136000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 1077115.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code APRES
NTLAIntellia Therapeutics, Inc.
Filing timeMar 04
Trade dateMar 01, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

NTLA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NTLA since 2025-03-04Filed 549 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0000950170-25-032248
Common Stock
Transaction date
Mar 01, 2025
Filed Mar 04, 2025, 09:41 PM · 3d delay
Shares
136k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
1.07M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

  2. F2

    Shares held by the John M. Leonard 2015 Irrevocable Trust.

  3. F3

    This option was granted on March 1, 2025 with respect to shares of Common Stock, with 33% vesting on January 1, 2026 and the remaining 67% vesting in 24 substantially equal monthly installments therea…

Original filing · 0000950170-25-032248
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NTLA